Skip to main content

Nalidixic acid Pregnancy and Breastfeeding Warnings

Brand names: NegGram

Nalidixic acid Pregnancy Warnings

Nalidixic acid has been assigned to pregnancy category C by the FDA. Animal studies have revealed teratogenic and embryocidal effects and prolonged pregnancy duration. There are no controlled data in human pregnancy. No birth defects were reported in 63 newborns whose mothers had taken the drug during pregnancy. Cartilage damage and arthropathy are reported in immature animals giving rise to concern over effects on bone formation in the developing fetus. Because safer alternatives are available, some experts consider quinolones contraindicated during pregnancy, especially during the first trimester. Nalidixic acid is only recommended for use during pregnancy when benefit outweighs risk.

See references

Nalidixic acid Breastfeeding Warnings

Nalidixic acid is excreted into human milk in small amounts (0.003% of the maternal dose). Hemolytic anemia has been reported in an infant with G6PD deficiency. The manufacturer considers nalidixic acid to be contraindicated during lactation.

See references

See also

References for pregnancy information

  1. "Product Information. Neggram (nalidixic acid)." Sanofi Winthrop Pharmaceuticals
  2. Briggs GG, Freeman RK, Yaffe SJ.. (1998) "Drugs in Pregnancy and Lactation." Baltimore, MD: Williams & Wilkins

References for breastfeeding information

  1. Belton EM, Jones RV (1965) "Haemolytic anaemia due to nalidixic acid." Lancet, 2, p. 691
  2. Roberts RJ, Blumer JL, Gorman RL, et al. (1989) "American Academy of Pediatrics Committee on Drugs: Transfer of drugs and other chemicals into human milk." Pediatrics, 84, p. 924-36
  3. "Product Information. Neggram (nalidixic acid)." Sanofi Winthrop Pharmaceuticals
  4. Committee on Drugs, 1992 to 1993 (1994) "The transfer of drugs and other chemicals into human milk." Pediatrics, 93, p. 137-50
  5. Briggs GG, Freeman RK, Yaffe SJ.. (1998) "Drugs in Pregnancy and Lactation." Baltimore, MD: Williams & Wilkins

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer